Market Capitalization – Big Pharma - Milken Institute
Market Capitalization – Big Pharma - Milken Institute
Market Capitalization – Big Pharma - Milken Institute
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Big</strong> <strong>Pharma</strong> vs. <strong>Big</strong> Biotech<br />
<strong>Market</strong> Cap Per Revenue, 2004<br />
<strong>Market</strong> Cap <strong>Market</strong> Cap/<br />
Company<br />
(US$ Billions) Revenue<br />
Pfizer (<strong>Pharma</strong>) 221 4.2<br />
GlaxoSmithKline 153 4.1<br />
Johnson & Johnson 183 3.9<br />
Merck 80 3.5<br />
Bristol-Myers Squibb 55 2.8<br />
AstraZeneca 58 2.7<br />
Sum / Average 750 3.7<br />
Genentech (Biotech) 57 12.3<br />
Biogen IDEC 23 10.5<br />
Elan 4 8.3<br />
Amgen 82 7.7<br />
Genzyme 15 6.9<br />
Chiron 7 4.0<br />
Sum / Average 187 8.6
Change language